• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Biochemical studies on muscarinic receptors.

作者信息

Massoulié J, Godwin S, Carson S, Kato G

出版信息

Biomedicine. 1977 Jul;26(4):250-9.

PMID:579159
Abstract

Muscarinic receptors have been characterized in smooth muscle and brain by the binding of reversible (e.g. atropine, quinuclidinylbenzylate) or irreversible (benzilylcholine or propylbenzilylcholine mustards) ligands. There is a close correlation between affinity constants derived from binding experiments and the affinities of muscarinic ligands for these sites obtained in pharmacological experiments on smooth muscle. Whereas atropine shows a single high affinity binding component (in subcellular preparations) several other ligands (QNB, ACh, oxotremorine) show multiple affinity binding. This indicated the existence of several types of binding sides which show selectivity toward certain cholinergic effectors. Most detergents inhibit the binding of ligands to the receptor site and therefore cannot be used to solubilize the receptor protein from the membrane. Treatment of brain subcellular membrane preparations with high salt concentrations (2M NaI) solubilize proteins which possess the muscarinic ligand binding properties observed in the membrane preparation. The affinities for muscarinic antagonists however are decreased, which suggests that a conformational change occurs in the protein upon solubilization.

摘要

相似文献

1
Biochemical studies on muscarinic receptors.
Biomedicine. 1977 Jul;26(4):250-9.
2
Muscarinic cholinergic receptor sites in cerebral blood vessels.
J Pharmacol Exp Ther. 1982 Apr;221(1):85-90.
3
Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.[3H]哌仑西平与从大鼠脑中溶解的毒蕈碱型胆碱能受体结合的特性研究。
J Pharmacol Exp Ther. 1985 Jul;234(1):37-44.
4
Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.通过抑制[3H]哌仑西平和[3H]喹核醇基苯甲酸酯与大鼠脑膜的结合来研究加拉明与毒蕈碱M1和M2受体的结合。
Mol Pharmacol. 1986 Jul;30(1):58-68.
5
Muscarinic receptors of the vascular bed: radioligand binding studies on bovine splenic veins.血管床的毒蕈碱受体:对牛脾静脉的放射性配体结合研究
J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):712-21.
6
Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.糖尿病大鼠膀胱过度活动症中M胆碱能受体功能、密度及G蛋白偶联
Auton Autacoid Pharmacol. 2006 Jul;26(3):303-9. doi: 10.1111/j.1474-8673.2006.00371.x.
7
Biochemical characterization of muscarinic receptors: multiplicity of binding components.
Prog Brain Res. 1979;49:303-11. doi: 10.1016/S0079-6123(08)64642-7.
8
The binding of antagonists to brain muscarinic receptors.拮抗剂与脑内毒蕈碱受体的结合。
Mol Pharmacol. 1978 Sep;14(5):737-50.
9
Decrease in (3H)-quinuclidinyl bezilate binding to the muscarinic cholinergic receptor in the longitudinal muscle of the rat ileum following chronic administration of diisopropylfuorophosphate.
Proc West Pharmacol Soc. 1977;20:1-7.
10
Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide.
Mol Pharmacol. 1982 May;21(3):594-9.